Agios Presents Mitapivat Data Highlighting Long-term Safety Profile and Durable Improvement in Hemoglobin and Markers of Hemolysis in Non-transfusion-dependent α- and β-Thalassemia at 63rd ASH Annual Meeting and Exposition

Ads

You May Also Like

Dynavax to Present at 37th Annual J.P. Morgan Healthcare Conference

BERKELEY, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a ...

Dermira to Present at Cowen and Company 37th Annual Health Care Conference

MENLO PARK, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical ...

CareDx Leadership in cfDNA Highlighted at CEoT

BRISBANE, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company ...